Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:471-475
Published online before print January 19, 2004, doi: 10.1161/01.CIR.0000109757.95461.10
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/4/471    most recent
01.CIR.0000109757.95461.10v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Best, L. G.
Right arrow Articles by Ferrell, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Best, L. G.
Right arrow Articles by Ferrell, R. E.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

(Circulation. 2004;109:471-475.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Prospective Analysis of Mannose-Binding Lectin Genotypes and Coronary Artery Disease in American Indians

The Strong Heart Study

Lyle G. Best, MD; Michael Davidson, MD, MPH, PhD; Kari E. North, PhD; Jean W. MacCluer, PhD; Ying Zhang, PhD; Elisa T. Lee, PhD; Barbara V. Howard, PhD; Susan DeCroo, MS; Robert E. Ferrell, PhD

From Missouri Breaks Industries Research Inc (L.G.B.), Timber Lake, SD; Medstar Research Institute (M.D., B.V.H.), Washington, DC; University of North Carolina (K.E.N.), Chapel Hill, NC; Southwest Foundation for Biomedical Research (J.W.M.), San Antonio, Tex; University of Oklahoma Health Sciences Center (Y.Z., E.T.L.), Oklahoma City, Okla; and University of Pittsburgh (S.D., R.E.F.), Pittsburgh, Pa.

Reprint requests to Lyle Best, MD, #1 Airport Rd, RR1, Box 88, Rolette, ND 58366. E-mail sbest{at}utma.com

Received June 16, 2003; de novo received September 18, 2003; accepted October 23, 2003.

Background— Mannose-binding lectin (MBL) is a circulating immune factor responsible for opsonization of pathogens and directly activating complement. Common variations in the MBL gene are responsible for an opsonic deficiency that affects 5% to 7% of whites and are associated with increased susceptibility to infections. After a preliminary report associating these variations with coronary artery disease (CAD), we determined MBL genotypes in 3 American Indian communities experiencing an increased mortality and morbidity from CAD.

Methods and Results— We examined DNA from 434 participants in a population-based cohort, the Strong Heart Study. Genotypes for 3 common MBL coding variations and 1 promoter polymorphism were determined. The frequency of a composite genotype that conferred low MBL levels was 20.7% in 217 cases and 11.1% in matched controls without CAD. A conditional logistic regression model indicated a univariate OR for CAD of 2.3 (95% CI 1.3 to 4.2, P=0.005) for the variant genotypes. After adjustment for demographic and CAD risk factors, including type 2 diabetes mellitus, fibrinogen, triglycerides, and hypertension, the OR was 3.2 (95% CI 1.5 to 7.0, P=0.004).

Conclusions— Variant MBL genotypes coding for markedly diminished levels of MBL are predictive of CAD. After adjustment for multiple traditional risk factors for ischemic heart disease, this association remains significant. A high prevalence of variant MBL alleles and CAD in this population suggests that potentially important public health benefits may accrue from future interventions based on these genotypes.


Key Words: coronary disease • genetics • inflammation • immune system • epidemiology




This article has been cited by other articles:


Home page
CirculationHome page
C. D. Collard, S. K. Shernan, A. A. Fox, T. Bernig, S. J. Chanock, W. K. Vaughn, K. Takahashi, A. B. Ezekowitz, P. Jarolim, and S. C. Body
The MBL2 'LYQA Secretor' Haplotype Is an Independent Predictor of Postoperative Myocardial Infarction in Whites Undergoing Coronary Artery Bypass Graft Surgery
Circulation, September 11, 2007; 116(11_suppl): I-106 - I-112.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. P. Berger, A. Roos, M. J.K. Mallat, A. F.M. Schaapherder, I. I. Doxiadis, C. van Kooten, F. W. Dekker, M. R. Daha, and J. W. de Fijter
Low Pretransplantation Mannose-Binding Lectin Levels Predict Superior Patient and Graft Survival after Simultaneous Pancreas-Kidney Transplantation
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2416 - 2422.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Jonsson, A. G. Sjoholm, L. Truedsson, A. A. Bengtsson, J. H. Braconier, and G. Sturfelt
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency
Rheumatology, July 1, 2007; 46(7): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
T. K. Hansen, M.-A. Gall, L. Tarnow, S. Thiel, C. D. Stehouwer, C. G. Schalkwijk, H.-H. Parving, and A. Flyvbjerg
Mannose-binding lectin and mortality in type 2 diabetes.
Arch Intern Med, October 9, 2006; 166(18): 2007 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. T. Keller, S. I. van Leuven, M. C. Meuwese, N. J. Wareham, R. Luben, E. S. Stroes, C. E. Hack, M. Levi, K.-T. Khaw, and S. M. Boekholdt
Serum Levels of Mannose-Binding Lectin and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2345 - 2350.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Rugonfalvi-Kiss, E. Dosa, H. O. Madsen, V. Endresz, Z. Prohaszka, J. Laki, I. Karadi, E. Gonczol, L. Selmeci, L. Romics, et al.
High Rate of Early Restenosis After Carotid Eversion Endarterectomy in Homozygous Carriers of the Normal Mannose-Binding Lectin Genotype
Stroke, May 1, 2005; 36(5): 944 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Saevarsdottir, O. O. Oskarsson, T. Aspelund, G. Eiriksdottir, T. Vikingsdottir, V. Gudnason, and H. Valdimarsson
Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk
J. Exp. Med., January 3, 2005; 201(1): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. K. Hansen, L. Tarnow, S. Thiel, R. Steffensen, C. D. Stehouwer, C. G. Schalkwijk, H.-H. Parving, and A. Flyvbjerg
Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes
Diabetes, June 1, 2004; 53(6): 1570 - 1576.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Dahl, A. Tybjaerg-Hansen, P. Schnohr, and B. G. Nordestgaard
A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency
J. Exp. Med., May 17, 2004; 199(10): 1391 - 1399.
[Abstract] [Full Text] [PDF]